Home
About
Overview
Sharing Data
ORCID
Help
History (13)
Patient-provider communications about pharmacogenomic results increase patient recall of medication changes.
MAGENTA (Making Genetic testing accessible): a prospective randomized controlled trial comparing online genetic education and telephone genetic counseling for hereditary cancer genetic testing.
Randomized trial of adjunctive topiramate therapy in infants with refractory partial seizures.
Characterizing and validating 12-month reliable cognitive change in Early-Onset Alzheimer's Disease for use in clinical trials.
New imaging modalities to distinguish rare uterine mesenchymal cancers from benign uterine lesions.
See All 13 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
New imaging modalities to distinguish rare uterine mesenchymal cancers from benign uterine lesions.
New imaging modalities to distinguish rare uterine mesenchymal cancers from benign uterine lesions. Curr Opin Oncol. 2021 09 01; 33(5):464-475.
View in:
PubMed
subject areas
Endometrial Neoplasms
Female
Humans
Magnetic Resonance Imaging
Sarcoma
Sarcoma, Endometrial Stromal
Uterine Neoplasms
authors with profiles
Elizabeth Kertowidjojo